EPO-906 (Novartis)
Galmarini, C.M.ía.; Dumontet, C.
Idrugs the Investigational Drugs Journal 6(12): 1182-1187
2003
ISSN/ISBN: 1369-7056 PMID: 14666430 Document Number: 555297
Novartis Pharma AG is developing EPO-906, an intravenous formulation microtubular depolymerization inhibitor (microtubule stabilizer), for the potential treatment of cancer.